Actinomycin D (Dactinomycin)

Catalog No.S8964 Batch:S896401

Print

Technical Data

Formula

C62H86N12O16
Molecular Weight 1255.42 CAS No. 50-76-0
Solubility (25°C)* In vitro DMSO 100 mg/mL (79.65 mM)
Water Insoluble
Ethanol Insoluble
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
* Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

Biological Activity

Description Actinomycin D (Dactinomycin, Act D, RASP-101) is a significant polypeptide antibiotic isolated from soil bacteria of the genus Streptomyces. Actinomycin D (Dactinomycin) inhibits DNA repair and rests the cell cycle at G1 phase with IC50 of 0.42 μM and 0.4 nM, respectively. Actinomycin D is an autophagy activator, induces p53-independent cell death and prolongs survival in high-risk chronic lymphocytic leukemia.This product is a hazardous chemical (acute toxicity/flammable/skin corrosive). Please use it while wearing a protective face mask, gloves, and clothing.
Targets
autophagy [3] cell cycle [1]
(Cell-based assay)		 DNA repair [2]
(Cell-free assay)
0.4 nM 0.42 μM
In vitro

Actinomycin D markedly reduces the SMC proliferation via the inhibition of BrdU incorporation at 80 nM. This is further supported by the G1-phase arrest using a flowcytometric analysis. The protein expression levels of proliferating cell nuclear antigen (PCNA), focal adhesion kinase (FAK), and Raf are all suppressed by actinomycin D. Extracellular signalregulated kinases (Erk) involved in cell-cycle arrest are found to be increased by actinomycin D.[1]
In vivo

Actinomycin D targets survival proteins TOSO, BCL2 and MCL1 and is active in two different mouse models that are characterized by either unmutated B-cell receptor or inactive p53 function, both of which are known negative prognostic factors in CLL.[3]

Protocol (from reference)

Cell Assay:

[1]
  • Cell lines

    A10 cells (Vascular SMC)

  • Concentrations

    80 nM, 800 nM, 8 μM

  • Incubation Time

    18-24 h

  • Method

    Cultured SMC are starved for 24 h followed by incubation with various doses of actinomycin D at 37℃. Drug treatment is carried out for 18-24 h. Since actinomycin D is dissolved in 0.1% DMSO, a vehicle control containing DMSO is also included.
Animal Study:

[3]
  • Animal Models

    C57BL/6 wild-type mice engrafted with tumor cells from Em-TCL-1 transgenic mice

  • Dosages

    0.06 mg/kg

  • Administration

    IP

Selleck's Actinomycin D (Dactinomycin) has been cited by 86 publications

Angiotension II directly bind P2X7 receptor to induce myocardial ferroptosis and remodeling by activating human antigen R [ Redox Biol, 2024, 72:103154] PubMed: 38626575
m6A-dependent upregulation of DDX21 by super-enhancer-driven IGF2BP2 and IGF2BP3 facilitates progression of acute myeloid leukaemia [ Clin Transl Med, 2024, 14(4):e1628] PubMed: 38572589
Targeting high circDNA2v levels in colorectal cancer induces cellular senescence and elicits an anti-tumor secretome [ Cell Rep, 2024, 43(4):114111] PubMed: 38615319
IGF2BP3 prevent HMGB1 mRNA decay in bladder cancer and development [ Cell Mol Biol Lett, 2024, 29(1):39] PubMed: 38504159
RNA m6A modification regulates L1 retrotransposons in human spermatogonial stem cell differentiation in vitro and in vivo [ Cell Mol Life Sci, 2024, 81(1):92] PubMed: 38363375
Exosomal circRHCG promotes breast cancer metastasis via facilitating M2 polarization through TFEB ubiquitination and degradation [ NPJ Precis Oncol, 2024, 8(1):22] PubMed: 38287113
METTL3-mediated m6A modification increases Hspa1a stability to inhibit osteoblast aging [ Cell Death Discov, 2024, 10(1):155] PubMed: 38538596
Bleomycin induces senescence and repression of DNA repair via downregulation of Rad51 [ Mol Med, 2024, 30(1):54] PubMed: 38649802
The RNA-binding protein RBMS3 inhibits the progression of colon cancer by regulating the stability of LIMS1 mRNA [ Cancer Med, 2024, 13(7):e7129] PubMed: 38618967
Role and mechanism of COL3A1 in regulating the growth, metastasis, and drug sensitivity in cisplatin-resistant non-small cell lung cancer cells [ Cancer Biol Ther, 2024, 25(1):2328382] PubMed: 38530094

RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.

SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.

NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.